Company Filing History:
Years Active: 2018
Title: Santiago Patricio Mendez Huergo: Innovator in Immuno-Modulation
Introduction
Santiago Patricio Mendez Huergo is a notable inventor based in Caba CP, Argentina. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of Galectin-1 polypeptide variants that have important immuno-modulating properties.
Latest Patents
Mendez Huergo holds a patent for "GAL-1 variants having immuno-modulating properties and methods of using the same." This patent describes Galectin-1 polypeptide variants that include a mutation of the histidine residue at position 52 of the full-length amino acid sequence of native human Gal-1. The mutation involves substituting histidine with tyrosine or asparagine, which provides resistance to acidosis that would otherwise deactivate native human Gal-1. Additionally, the variants may include one or more mutations of the cysteine residue at positions 2, 16, or 88, with substitutions to serine, offering resistance to oxidation.
Career Highlights
Throughout his career, Mendez Huergo has worked with esteemed organizations such as the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) and Fundación Sales. His research has contributed to advancements in understanding the immunological functions of Galectin-1 and its potential therapeutic applications.
Collaborations
Mendez Huergo has collaborated with notable colleagues, including Gabriel Adrián Rabinovich and Santiago Di Lella. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Santiago Patricio Mendez Huergo is a distinguished inventor whose work in immuno-modulation has the potential to impact medical science significantly. His innovative patents and collaborations reflect his commitment to advancing research in immunology.